MMP-25 metalloprotease regulates innate immune response through NF-κB signaling

Journal of Immunology

Volumn 197, Issue 1, 2016, Pages 296-302

  Soria Valles, Clara ^a   Gutiérrez Fernández, Ana ^a   Osorio, Fernando G ^a   Carrero, Dido ^a   Ferrando, Adolfo A ^b   Colado, Enrique ^c   Fernández García, M Soledad ^c   Bonzon Kulichenko, Elena ^d   Vázquez, Jesús ^d   Fueyo, Antonio ^a   López Otín, Carlos ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b Columbia University ^*  (United States)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 25; UNCLASSIFIED DRUG; AUTACOID; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; PROTEIN BINDING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HYPERGAMMAGLOBULINEMIA; IMMUNOPATHOLOGY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; KNOCKOUT MOUSE; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CELL CULTURE; GENETICS; IMMUNOLOGY; METABOLISM;

ANIMALS; CELLS, CULTURED; CYTOKINES; GPI-LINKED PROTEINS; HYPERGAMMAGLOBULINEMIA; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; LEUKOCYTES; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 84975303482     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600094     Document Type: Article

References (41)

1. Newson, J.,M. Stables, E. Karra, F. Arce-Vargas, S. Quezada,M.Motwani,M.Mack, S. Yona, T. Audzevich, and D. W. Gilroy. 2014. Resolution of acute inflammation bridges the gap between innate and adaptive immunity. Blood 124: 1748-1764.
2. Bonnans, C., J. Chou, and Z. Werb. 2014. Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol. 15: 786-801.
3. Puente, X. S., L. M. Sánchez, C. M. Overall, and C. López-Otín. 2003. Human and mouse proteases: A comparative genomic approach. Nat. Rev. Genet. 4: 544-558.
4. Soria-Valles, C., A. Gutiérrez-Fernández, M. Guiu, B. Mari, A. Fueyo, R. R. Gomis, and C. López-Otín. 2014. The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21. Oncogene 33: 3054-3063.
5. Gutiérrez-Fernández, A., C. Soria-Valles, F. G. Osorio, J. Gutiérrez-Abril, C. Garabaya, A. Aguirre, A. Fueyo, M. S. Fernández-García, X. S. Puente, and C. López-Otín. 2015. Loss of MT1-MMP causes cell senescence and nuclear defects which can be reversed by retinoic acid. EMBO J. 34: 1875-1888.
6. Fanjul-Fernández, M., A. R. Folgueras, S. Cabrera, and C. López-Otín. 2010. Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim. Biophys. Acta 1803: 3-19.
7. Velasco, G., S. Cal, A. Merlos-Suárez, A. A. Ferrando, S. Alvarez, A. Nakano, J. Arribas, and C. López-Otín. 2000. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. Cancer Res. 60: 877-882.
8. Kojima, S., Y. Itoh, S. Matsumoto, Y. Masuho, and M. Seiki. 2000. Membranetype 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosylphosphatidyl inositol (GPI)-anchored MMP. FEBS Lett. 480: 142-146.
9. Huang,W. C., G. B. Sala-Newby, A. Susana, J. L. Johnson, and A. C. Newby. 2012. Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-kB. PLoS One 7: e42507.
10. English, W. R., G. Velasco, J. O. Stracke, V. Knäuper, and G. Murphy. 2001. Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25). FEBS Lett. 491: 137-142.
11. Bar-Or, A., R. K. Nuttall, M. Duddy, A. Alter, H. J. Kim, I. Ifergan, C. J. Pennington, P. Bourgoin, D. R. Edwards, and V. W. Yong. 2003. Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain 126: 2738-2749.
12. Sun, Q., C. R. Weber, A. Sohail, M. M. Bernardo, M. Toth, H. Zhao, J. R. Turner, and R. Fridman. 2007. MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties. J. Biol. Chem. 282: 21998-22010.
13. Balbín, M., A. Fueyo, A. M. Tester, A. M. Pendás, A. S. Pitiot, A. Astudillo, C. M. Overall, S. D. Shapiro, and C. López-Otín. 2003. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat. Genet. 35: 252-257.
14. Fanjul-Fernández, M., A. R. Folgueras, A. Fueyo, M. Balbín, M. F. Suárez, M. S. Fernández-García, S. D. Shapiro, J. M. Freije, and C. López-Otín. 2013. Matrix metalloproteinase Mmp-1a is dispensable for normal growth and fertility in mice and promotes lung cancer progression by modulating inflammatory responses. J. Biol. Chem. 288: 14647-14656.
15. Folgueras, A. R., F. M. de Lara, A. M. Pendás, C. Garabaya, F. Rodríguez, A. Astudillo, T. Bernal, R. Cabanillas, C. López-Otín, and G. Velasco. 2008. Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. Blood 112: 2539-2545.
16. Folgueras, A. R., T. Valdés-Sánchez, E. Llano, L. Menéndez, A. Baamonde, B. L. Denlinger, C. Belmonte, L. Juárez, A. Lastra, O. García-Suárez, et al. 2009. Metalloproteinase MT5-MMP is an essential modulator of neuroimmune interactions in thermal pain stimulation. Proc. Natl. Acad. Sci. USA 106: 16451-16456.
17. Hu, Y. 2012. Isolation of human and mouse neutrophils ex vivo and in vitro. Methods Mol. Biol. 844: 101-113.
18. Pétrilli, V., Z. Herceg, P. O. Hassa, N. S. Patel, R. Di Paola, U. Cortes, L. Dugo, H. M. Filipe, C. Thiemermann, M. O. Hottiger, et al. 2004. Noncleavable poly (ADP-ribose) polymerase-1 regulates the inflammation response in mice. J. Clin. Invest. 114: 1072-1081.
19. Osorio, F. G., C. Soria-Valles, O. Santiago-Fernández, T. Bernal, M. Mittelbrunn, E. Colado, F. Rodríguez, E. Bonzon-Kulichenko, J. Vázquez, M. Porta-de-la-Riva, et al. 2016. Loss of the proteostasis factor AIRAPL causes myeloid transformation by deregulating IGF-1 signaling. Nat. Med. 22: 91-96.
20. Osorio, F. G., J. de la Rosa, and J. M. Freije. 2013. Luminescence-based in vivo monitoring of NF-kB activity through a gene delivery approach. Cell Commun. Signal. 11: 19.
21. Kiel, M. J., O. H. Yilmaz, T. Iwashita, O. H. Yilmaz, C. Terhorst, and S. J. Morrison. 2005. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121: 1109-1121.
22. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res. 17: 6419.
23. Villarroya-Beltri, C., C. Gutiérrez-Vázquez, F. Sánchez-Cabo, D. Pérez-Hernández, J. Vázquez, N. Martin-Cofreces, D. J. Martinez-Herrera, A. Pascual-Montano, M. Mittelbrunn, and F. Sánchez-Madrid. 2013. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat. Commun. 4: 2980.
24. Starr, A. E., C. L. Bellac, A. Dufour, V. Goebeler, and C. M. Overall. 2012. Biochemical characterization and N-terminomics analysis of leukolysin, the membrane-type 6 matrix metalloprotease (MMP25): chemokine and vimentin cleavages enhance cell migration and macrophage phagocytic activities. J. Biol. Chem. 287: 13382-13395.
25. Peruzzi, G., L. Femnou, A. Gil-Krzewska, F. Borrego, J.Weck, K. Krzewski, and J. E. Coligan. 2013. Membrane-type 6 matrix metalloproteinase regulates the activation-induced downmodulation of CD16 in human primary NK cells. J. Immunol. 191: 1883-1894.
26. Kang, T., J. Yi, A. Guo, X. Wang, C. M. Overall, W. Jiang, R. Elde, N. Borregaard, and D. Pei. 2001. Subcellular distribution and cytokine-and chemokine-regulated secretion of leukolysin/MT6-MMP/MMP-25 in neutrophils. J. Biol. Chem. 276: 21960-21968.
27. Hayden, M. S., and S. Ghosh. 2011. NF-kB in immunobiology. Cell Res. 21: 223-244.
28. Erener, S., V. Pétrilli, I. Kassner, R. Minotti, R. Castillo, R. Santoro, P. O. Hassa, J. Tschopp, and M. O. Hottiger. 2012. Inflammasome-activated caspase 7 cleaves PARP1 to enhance the expression of a subset of NF-kB target genes. Mol. Cell 46: 200-211.
29. Oliver, F. J., J. Ménissier-de Murcia, C. Nacci, P. Decker, R. Andriantsitohaina, S. Muller, G. de la Rubia, J. C. Stoclet, and G. de Murcia. 1999. Resistance to endotoxic shock as a consequence of defective NF-kB activation in poly(ADPribose) polymerase-1 deficient mice. EMBO J. 18: 4446-4454.
30. Deng, L., C. Wang, E. Spencer, L. Yang, A. Braun, J. You, C. Slaughter, C. Pickart, and Z. J. Chen. 2000. Activation of the IkB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103: 351-361.
31. Lamothe, B., A. Besse, A. D. Campos, W. K. Webster, H. Wu, and B. G. Darnay. 2007. Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of IkB kinase activation. J. Biol. Chem. 282: 4102-4112.
32. Pulvino, M., Y. Liang, D. Oleksyn, M. DeRan, E. Van Pelt, J. Shapiro, I. Sanz, L. Chen, and J. Zhao. 2012. Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitinconjugating enzyme Ubc13-Uev1A. Blood 120: 1668-1677.
33. Arango Duque, G., and A. Descoteaux. 2014. Macrophage cytokines: involvement in immunity and infectious diseases. Front. Immunol. 5: 491.
34. Nissinen, L., and V. M. Kähäri. 2014. Matrix metalloproteinases in inflammation. Biochim. Biophys. Acta 1840: 2571-2580.
35. Godefroy, E., O. Manches, B. Dréno, T. Hochman, L. Rolnitzky, N. Labarrière, Y. Guilloux, J. Goldberg, F. Jotereau, and N. Bhardwaj. 2011. Matrix metalloproteinase-2 conditions human dendritic cells to prime inflammatory T(H)2 cells via an IL-12- and OX40L-dependent pathway. Cancer Cell 19: 333-346.
36. Folgueras, A. R., A. Fueyo, O. García-Suárez, J. Cox, A. Astudillo, P. Tortorella, C. Campestre, A. Gutiérrez-Fernández, M. Fanjul-Fernández, C. J. Pennington, et al. 2008. Collagenase-2 deficiency or inhibition impairs experimental autoimmune encephalomyelitis in mice. J. Biol. Chem. 283: 9465-9474.
37. Gutiérrez-Fernández, A., M. Inada, M. Balbín, A. Fueyo, A. S. Pitiot, A. Astudillo, K. Hirose, M. Hirata, S. D. Shapiro, A. Noël, et al. 2007. Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8). FASEB J. 21: 2580-2591.
38. Soria-Valles, C., F. G. Osorio, A. Gutiérrez-Fernández, A. De Los Angeles, C. Bueno, P. Menéndez, J. I. Martín-Subero, G. Q. Daley, J. M. Freije, and C. López-Otín. 2015. NF-kB activation impairs somatic cell reprogramming in ageing. Nat. Cell Biol. 17: 1004-1013.
39. Osorio, F. G., C. Bárcena, C. Soria-Valles, A. J. Ramsay, F. de Carlos, J. Cobo, A. Fueyo, J. M. Freije, and C. López-Otín. 2012. Nuclear lamina defects cause ATM-dependent NF-kB activation and link accelerated aging to a systemic inflammatory response. Genes Dev. 26: 2311-2324.
40. López-Otín, C., M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer. 2013. The hallmarks of aging. Cell 153: 1194-1217.
41. Marco, M., C. Fortin, and T. Fulop. 2013. Membrane-type matrix metalloproteinases: key mediators of leukocyte function. J. Leukoc. Biol. 94: 237-246.